In a separate study, melanoma-associated retrovirus was targeted using virus-like particles encoding the envelope with a mutated ISD (Env ISDmut) as a surface target to improve the immunogenicity and efficacy of the vaccine (105). This evidence concerns the gene ERVW-1 and melanoma.